Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.617
+0.017 (2.83%)
At close: Jan 21, 2025, 4:00 PM
0.644
+0.027 (4.39%)
After-hours: Jan 21, 2025, 5:54 PM EST
Passage Bio Employees
Passage Bio had 58 employees as of December 31, 2023. The number of employees decreased by 27 or -31.76% compared to the previous year.
Employees
58
Change (1Y)
-27
Growth (1Y)
-31.76%
Revenue / Employee
n/a
Profits / Employee
-$1,186,207
Market Cap
38.11M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58 | -27 | -31.76% |
Dec 31, 2022 | 85 | -48 | -36.09% |
Dec 31, 2021 | 133 | 59 | 79.73% |
Dec 31, 2020 | 74 | 54 | 270.00% |
Dec 31, 2019 | 20 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PASG News
- 11 days ago - Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates - GlobeNewsWire
- 2 months ago - Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire
- 3 months ago - Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference - GlobeNewsWire
- 4 months ago - Passage Bio to Present at Chardan's 8th Annual Genetic Medicines Conference - GlobeNewsWire
- 4 months ago - Passage Bio Welcomes Tom Kassberg to Board of Directors - GlobeNewsWire
- 5 months ago - Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 5 months ago - Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 6 months ago - Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration - GlobeNewsWire